BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 19068715)

  • 1. [Different strategies between Japan and other countries for the diagnosis and treatment of rectal cancer].
    Watanabe T
    Nihon Geka Gakkai Zasshi; 2008 Nov; 109(6):338-42. PubMed ID: 19068715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current status of autonomic nerve-preserving surgery for mid and lower rectal cancers: Japanese experience with lateral node dissection.
    Morita T; Murata A; Koyama M; Totsuka E; Sasaki M
    Dis Colon Rectum; 2003 Oct; 46(10 Suppl):S78-87; discussion S87-8. PubMed ID: 14530662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncologic and functional results of total mesorectal excision and autonomic nerve-preserving operation for advanced lower rectal cancer.
    Shirouzu K; Ogata Y; Araki Y
    Dis Colon Rectum; 2004 Sep; 47(9):1442-7. PubMed ID: 15486739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Local recurrence and survival rate after rectal cancer operations and multimodal therapy].
    Thomschke D; Kyau-Ummen B; Halbfass HJ
    Chirurg; 2002 Mar; 73(3):245-54. PubMed ID: 11963499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Laparoscopic pelvic autonomic nerve-preserving surgery for patients with lower rectal cancer after chemoradiation therapy.
    Liang JT; Lai HS; Lee PH
    Ann Surg Oncol; 2007 Apr; 14(4):1285-7. PubMed ID: 17235719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Total mesorectal excision with autonomic nerve preservation: a new foundation for the evaluation of multi-disciplinary adjuvant therapy in the management of rectal cancers.
    Kafka NJ; Enker WE
    Ann Chir; 1999; 53(10):996-1002. PubMed ID: 10670148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Neoadjuvant chemoradiation therapy for locally advanced rectal cancer].
    Sato T; Ozawa H; Kisyu K; Kumamoto H; Nakamura T; Onozato W; Yamanashi T; Kokuba Y; Ihara A; Watanabe M
    Gan To Kagaku Ryoho; 2007 Oct; 34(10):1553-6. PubMed ID: 17940371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The autonomic nerve preserving radical resection for the patients with lower rectal cancer].
    Mori T; Takahashi K; Yasuno M
    Nihon Geka Gakkai Zasshi; 1997 Mar; 98(3):385-90. PubMed ID: 9101546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laparoscopic mesorectal excision with preservation of the pelvic autonomic nerves for rectal cancer.
    Fukunaga Y; Higashino M; Tanimura S; Kishida S; Fujiwara Y; Ogata A; Osugi H
    Hepatogastroenterology; 2007; 54(73):85-90. PubMed ID: 17419237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant chemotherapy with uracil-tegafur for pathological stage III rectal cancer after mesorectal excision with selective lateral pelvic lymphadenectomy: a multicenter randomized controlled trial.
    Akasu T; Moriya Y; Ohashi Y; Yoshida S; Shirao K; Kodaira S;
    Jpn J Clin Oncol; 2006 Apr; 36(4):237-44. PubMed ID: 16675478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lateral pelvic lymph node dissection or chemoradiotherapy: which is the procedure of choice to reduce local recurrence rate in lower rectal cancer?
    Watanabe T; Matsuda K; Nozawa K; Kobunai T
    Ann Surg; 2008 Aug; 248(2):342-3; author reply 343. PubMed ID: 18650647
    [No Abstract]   [Full Text] [Related]  

  • 12. Indication and benefit of pelvic sidewall dissection for rectal cancer.
    Sugihara K; Kobayashi H; Kato T; Mori T; Mochizuki H; Kameoka S; Shirouzu K; Muto T
    Dis Colon Rectum; 2006 Nov; 49(11):1663-72. PubMed ID: 17041749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of autonomic nerve preservation and lateral node dissection on male urogenital function after total mesorectal excision for lower rectal cancer.
    Kyo K; Sameshima S; Takahashi M; Furugori T; Sawada T
    World J Surg; 2006 Jun; 30(6):1014-9. PubMed ID: 16736330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant radiation therapy in resectable rectal cancer: should local recurrence rates affect the decision?
    Kim NK; Senagore AJ; Luchtefeld MA; MacKeigan JM; Mazier WP; Belknap K
    Am Surg; 1997 Jul; 63(7):579-84; discussion 584-5. PubMed ID: 9202530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Total excision of the mesorectum in cancer of the lower and middle rectum. Oncological and functional results].
    Kneist W; Heintz A; Wolf HK; Junginger T
    Chirurg; 2003 Feb; 74(2):125-31. PubMed ID: 12599030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current surgical management of rectal cancer.
    Kusunoki M; Inoue Y
    Dig Surg; 2007; 24(2):115-9. PubMed ID: 17446705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Local excision and endoscopic posterior mesorectal resection versus low anterior resection in T1 rectal cancer.
    Tarantino I; Hetzer FH; Warschkow R; Zünd M; Stein HJ; Zerz A
    Br J Surg; 2008 Mar; 95(3):375-80. PubMed ID: 18278781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomised clinical trial of adjuvant postoperative RT vs. sequential postoperative RT plus 5-FU and levamisole in patients with stage II-III resectable rectal cancer: a final report.
    Cafiero F; Gipponi M; Lionetto R;
    J Surg Oncol; 2003 Jul; 83(3):140-6. PubMed ID: 12827681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [[Lymphadenectomy in carcinoma of the rectum: standard surgery and frontier surgery].
    Di Matteo G; Peparini N
    G Chir; 2000 Oct; 21(10):365-7. PubMed ID: 11126732
    [No Abstract]   [Full Text] [Related]  

  • 20. Incidence and prognostic significance of lateral lymph node metastasis in patients with advanced low rectal cancer.
    Ueno M; Oya M; Azekura K; Yamaguchi T; Muto T
    Br J Surg; 2005 Jun; 92(6):756-63. PubMed ID: 15838895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.